Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 515

1.

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.

Coates LC, Mahmood F, Freeston J, Emery P, Conaghan PG, Helliwell PS.

Rheumatology (Oxford). 2019 Aug 31. pii: kez369. doi: 10.1093/rheumatology/kez369. [Epub ahead of print]

PMID:
31504996
2.

Statin Use and Knee Osteoarthritis Outcome Measures according to the Presence of Heberden Nodes: Results from the Osteoarthritis Initiative.

Haj-Mirzaian A, Mohajer B, Guermazi A, Conaghan PG, Lima JAC, Blaha MJ, Bingham CO, Roemer FW, Cao X, Demehri S.

Radiology. 2019 Sep 10:190557. doi: 10.1148/radiol.2019190557. [Epub ahead of print]

PMID:
31502936
3.

Predicting disease progression and poor outcomes in patients with moderately active rheumatoid arthritis: a systematic review.

Edwards CJ, Kiely P, Arthanari S, Kiri S, Mount J, Barry J, Mitchell CR, Field P, Conaghan PG.

Rheumatol Adv Pract. 2019 Feb 15;3(1):rkz002. doi: 10.1093/rap/rkz002. eCollection 2019.

4.

Update on novel pharmacological therapies for osteoarthritis.

Ghouri A, Conaghan PG.

Ther Adv Musculoskelet Dis. 2019 Jul 23;11:1759720X19864492. doi: 10.1177/1759720X19864492. eCollection 2019. Review.

5.

Developing a standardized approach to virtual clinic follow-up of hip and knee arthroplasty.

Preston N, McHugh GA, Hensor EMA, Grainger AJ, O'Connor PJ, Conaghan PG, Stone MH, Kingsbury SR.

Bone Joint J. 2019 Aug;101-B(8):951-959. doi: 10.1302/0301-620X.101B8.BJJ-2018-1566.R1.

PMID:
31362551
6.

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.

Mortimer I, Bissell LA, Hensor EMA, Kozera L, Mackie SL, Burska AN, Nam JL, Keen H, Villeneuve E, Donica H, Buch MH, Conaghan PG, Emery P, Morgan AW, Andrews J.

Rheumatology (Oxford). 2019 Sep 1;58(9):1684-1686. doi: 10.1093/rheumatology/kez114. No abstract available.

7.

Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULAR.

Mandl P, Ciechomska A, Terslev L, Baraliakos X, Conaghan PG, D'Agostino MA, Iagnocco A, van der Laken CJ, Ostergaard M, Naredo E.

RMD Open. 2019 Jun 25;5(2):e000950. doi: 10.1136/rmdopen-2019-000950. eCollection 2019.

8.

Determining MRI Inflammation Targets When Considering a Rheumatoid Arthritis Treat-to-Target Strategy: Results of a Randomized, Placebo-Controlled Trial.

Ahmad HA, Baker JF, Østergaard M, Ye J, Emery P, Conaghan PG.

Adv Ther. 2019 Sep;36(9):2384-2393. doi: 10.1007/s12325-019-01020-6. Epub 2019 Jul 5.

9.

Towards UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): protocol for an evaluation of the requirements for arthroplasty follow-up, and the production of consensus-based recommendations.

Czoski Murray CJ, Kingsbury SR, Arden NK, Hewison J, Judge A, Matu J, O'Shea J, Pinedo-Villanueva R, Smith LK, Smith C, Thomas CM, West RM, Wright JM, Conaghan PG, Stone MH.

BMJ Open. 2019 Jun 25;9(6):e031351. doi: 10.1136/bmjopen-2019-031351.

10.

Toward the Development of Data-Driven Diagnostic Subgroups for People With Patellofemoral Pain Using Modifiable Clinical, Biomechanical, and Imaging Features.

Drew BT, Conaghan PG, Smith TO, Selfe J, Hensor EMA, Dube B, Grainger AJ, Redmond AC.

J Orthop Sports Phys Ther. 2019 Jul;49(7):536-547. doi: 10.2519/jospt.2019.8607. Epub 2019 Jun 18.

PMID:
31213159
11.

Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.

Guillemin F, Ricatte C, Barcenilla-Wong A, Schoumacker A, Cross M, Alleyrat C, Buttel T, Cembalo M, Manseur H, Urban H, Fautrel B, Conaghan PG, Hawker G, Rutherford C, March L, Spitz E, Hunter DJ.

J Rheumatol. 2019 Sep;46(9):1188-1191. doi: 10.3899/jrheum.181085. Epub 2019 May 15.

PMID:
31092709
12.

Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis.

Burska AN, Thu A, Parmar R, Bzoma I, Samans B, Raschke E, Olek S, Conaghan PG, Emery P, Ponchel F.

Rheumatology (Oxford). 2019 May 12. pii: kez162. doi: 10.1093/rheumatology/kez162. [Epub ahead of print]

PMID:
31081041
13.

Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Honvo G, Bannuru RR, Bruyère O, Rannou F, Herrero-Beaumont G, Uebelhart D, Cooper C, Arden N, Conaghan PG, Reginster JY, Thomas T, McAlindon T.

Drugs Aging. 2019 Apr;36(Suppl 1):145-159. doi: 10.1007/s40266-019-00667-8.

14.

Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.

Fuggle N, Curtis E, Shaw S, Spooner L, Bruyère O, Ntani G, Parsons C, Conaghan PG, Corp N, Honvo G, Uebelhart D, Baird J, Dennison E, Reginster JY, Cooper C.

Drugs Aging. 2019 Apr;36(Suppl 1):129-143. doi: 10.1007/s40266-019-00666-9.

15.

Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?

Conaghan PG, Arden N, Avouac B, Migliore A, Rizzoli R.

Drugs Aging. 2019 Apr;36(Suppl 1):7-14. doi: 10.1007/s40266-019-00658-9. Review.

16.

Importance of Safety in the Management of Osteoarthritis and the Need for Updated Meta-Analyses and Recommendations for Reporting of Harms.

Reginster JY, Bruyère O, Conaghan PG, McAlindon T, Cooper C.

Drugs Aging. 2019 Apr;36(Suppl 1):3-6. doi: 10.1007/s40266-019-00659-8. No abstract available.

17.

Therapeutic options for targeting inflammatory osteoarthritis pain.

Conaghan PG, Cook AD, Hamilton JA, Tak PP.

Nat Rev Rheumatol. 2019 Jun;15(6):355-363. doi: 10.1038/s41584-019-0221-y. Review.

PMID:
31068673
18.
19.

Recommendations for acquisition and interpretation of MRI of the spine and sacroiliac joints in the diagnosis of axial spondyloarthritis in the UK.

Bray TJP, Jones A, Bennett AN, Conaghan PG, Grainger A, Hodgson R, Hutchinson C, Leandro M, Mandl P, McGonagle D, O'Connor P, Sengupta R, Thomas M, Toms A, Winn N, Hall-Craggs MA, Marzo-Ortega H, Machado PM; British Society of Spondyloarthritis (BRITSpA).

Rheumatology (Oxford). 2019 May 2. pii: kez173. doi: 10.1093/rheumatology/kez173. [Epub ahead of print]

PMID:
31046100
20.

Practical guidance for engaging patients in health research, treatment guidelines and regulatory processes: results of an expert group meeting organized by the World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

de Wit M, Cooper C, Tugwell P, Bere N, Kirwan J, Conaghan PG, Roberts C, Aujoulat I, Al-Daghri N, Araujo de Carvalho I, Barker M, Bedlington N, Brandi ML, Bruyère O, Burlet N, Halbout P, Hiligsmann M, Jiwa F, Kanis JA, Laslop A, Lawrence W, Pinto D, Prieto Yerro C, Rabenda V, Rizzoli R, Scholte-Voshaar M, Vlaskovska M, Reginster JY.

Aging Clin Exp Res. 2019 Jul;31(7):905-915. doi: 10.1007/s40520-019-01193-8. Epub 2019 Apr 16. Review.

21.

Precision, Reliability, and Responsiveness of a Novel Automated Quantification Tool for Cartilage Thickness: Data from the Osteoarthritis Initiative.

Bowes MA, Guillard GA, Vincent GR, Brett AD, Wolstenholme CBH, Conaghan PG.

J Rheumatol. 2019 Apr 15. pii: jrheum.180541. doi: 10.3899/jrheum.180541. [Epub ahead of print]

PMID:
30988122
22.

Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis.

Langworthy MJ, Conaghan PG, Ruane JJ, Kivitz AJ, Lufkin J, Cinar A, Kelley SD.

Adv Ther. 2019 Jun;36(6):1398-1411. doi: 10.1007/s12325-019-00944-3. Epub 2019 Apr 9.

23.

Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.

Chiarotto A, Kaiser U, Choy E, Christensen R, Conaghan PG, Cowern M, Gill M, de Wit M, Gargon E, Horgan B, Kirkham JJ, Simon LS, Singh JA, Tugwell P, Turk DC, Mease PJ.

J Rheumatol. 2019 Apr 1. pii: jrheum.181099. doi: 10.3899/jrheum.181099. [Epub ahead of print]

PMID:
30936284
24.

Corticosteroids and osteoarthritis progression: a confounded issue.

Conaghan PG.

Osteoarthritis Cartilage. 2019 Jun;27(6):e5-e6. doi: 10.1016/j.joca.2019.02.799. Epub 2019 Mar 18. No abstract available.

PMID:
30898622
25.

The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example.

Terslev L, Naredo E, Keen HI, Bruyn GAW, Iagnocco A, Wakefield RJ, Conaghan PG, Maxwell LJ, Beaton DE, Boers M, D'Agostino MA.

J Rheumatol. 2019 Mar 15. pii: jrheum.181158. doi: 10.3899/jrheum.181158. [Epub ahead of print]

PMID:
30877208
26.

Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.

Maynard C, Mikuls TR, Cannon GW, England BR, Conaghan PG, Østergaard M, Baker DG, Kerr G, George MD, Barton JL, Baker JF.

Arthritis Care Res (Hoboken). 2019 Mar 15. doi: 10.1002/acr.23873. [Epub ahead of print]

PMID:
30875461
27.

Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Hensor EMA, McKeigue P, Ling SF, Colombo M, Barrett JH, Nam JL, Freeston J, Buch MH, Spiliopoulou A, Agakov F, Kelly S, Lewis MJ, Verstappen SMM, MacGregor AJ, Viatte S, Barton A, Pitzalis C, Emery P, Conaghan PG, Morgan AW.

Rheumatology (Oxford). 2019 Mar 1. pii: kez049. doi: 10.1093/rheumatology/kez049. [Epub ahead of print]

28.

Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017.

Smith TO, Mansfield M, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Aug;46(8):976-980. doi: 10.3899/jrheum.181066. Epub 2019 Mar 1.

PMID:
30824657
29.

OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies.

Boers M, Beaton DE, Shea BJ, Maxwell LJ, Bartlett SJ, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March L, Simon LS, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1021-1027. doi: 10.3899/jrheum.181096. Epub 2019 Feb 15.

PMID:
30770515
30.

Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS).

Sundin U, Østergaard M, Glinatsi D, Aga AB, Hørslev-Petersen K, Hetland ML, Stengard-Pedersen K, Junker P, Ejbjerg BJ, Bird P, Conaghan PG, Lillegraven S, Haavardsholm EA.

J Rheumatol. 2019 Sep;46(9):1222-1227. doi: 10.3899/jrheum.181064. Epub 2019 Feb 15.

PMID:
30770509
31.

Development and Validation of an OMERACT MRI Whole-Body Score for Inflammation in Peripheral Joints and Entheses in Inflammatory Arthritis (MRI-WIPE).

Krabbe S, Eshed I, Gandjbakhch F, Pedersen SJ, Bird P, Mathew AJ, Lambert RG, Maksymowych WP, Glinatsi D, Stoenoiu MS, Poggenborg R, Jans L, Jaremko JL, Herregods N, Foltz V, Conaghan PG, Althoff CE, Paschke J, Peterfy C, Hermann KA, Østergaard M; for the OMERACT MRI in Arthritis Working Group.

J Rheumatol. 2019 Sep;46(9):1215-1221. doi: 10.3899/jrheum.181084. Epub 2019 Feb 15.

PMID:
30770508
32.

Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology.

Maxwell LJ, Beaton DE, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit M, Gossec L, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1014-1020. doi: 10.3899/jrheum.181097. Epub 2019 Feb 15.

PMID:
30770502
33.

Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis Magnetic Resonance Imaging Score (OMERACT JAMRIS-SIJ).

Otobo TM, Conaghan PG, Maksymowych WP, van der Heijde D, Weiss P, Sudol-Szopinska I, Herregods N, Jaremko JL, Meyers AB, Rumsey D, Inarejos EC, Kirkhus E, Stimec J, Panwar J, Thorpe K, Jans L, van Rossum MA, Tolend M, Perez M, Tzaribachev N, Sandhya P, Tse S, Simone A, Swami VG, Touma Z, Lambert R, Doria AS.

J Rheumatol. 2019 Sep;46(9):1192-1197. doi: 10.3899/jrheum.181115. Epub 2019 Feb 15.

PMID:
30770500
34.

Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study.

Alten R, Conaghan PG, Strand V, Sullivan E, Blackburn S, Tian H, Gandhi K, Jugl SM, Deodhar A.

Clin Rheumatol. 2019 Jun;38(6):1615-1626. doi: 10.1007/s10067-019-04446-z. Epub 2019 Feb 4.

PMID:
30719594
35.

The OMERACT MRI in Enthesitis Initiative: Definitions of Key Pathologies, Suggested MRI Sequences, and a Novel Heel Enthesitis Scoring System.

Mathew AJ, Krabbe S, Eshed I, Gandjbakhch F, Bird P, Pedersen SJ, Stoenoiu MS, Foltz V, Glinatsi D, Lambert RG, Hermann KGA, Maksymowych WP, Haugen IK, Jaremko JL, Poggenborg RP, Paschke J, Laredo JD, Carron P, Conaghan PG, Østergaard M.

J Rheumatol. 2019 Sep;46(9):1232-1238. doi: 10.3899/jrheum.181093. Epub 2019 Feb 1.

PMID:
30709961
36.

Utility of Magnetic Resonance Imaging in Diagnosis and Monitoring Enthesitis in Patients with Spondyloarthritis: An OMERACT Systematic Literature Review.

Mathew AJ, Krabbe S, Kirubakaran R, Barr AJ, Conaghan PG, Bird P, Østergaard M.

J Rheumatol. 2019 Sep;46(9):1207-1214. doi: 10.3899/jrheum.181083. Epub 2019 Feb 1.

PMID:
30709955
37.

Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.

Beaton DE, Maxwell LJ, Shea BJ, Wells GA, Boers M, Grosskleg S, Bingham CO 3rd, Conaghan PG, D'Agostino MA, de Wit MP, Gossec L, March LM, Simon LS, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2019 Aug;46(8):1028-1035. doi: 10.3899/jrheum.181218. Epub 2019 Feb 1.

PMID:
30709952
38.

The OMERACT Core Domain Set for Clinical Trials of Shoulder Disorders.

Ramiro S, Page MJ, Whittle SL, Huang H, Verhagen AP, Beaton DE, Richards P, Voshaar M, Shea B, van der Windt DA, Kopkow C, Lenza M, Jain NB, Richards B, Hill C, Gill TK, Koes B, Foster NE, Conaghan PG, Smith T, Malliaras P, Roe Y, Gagnier JJ, Buchbinder R.

J Rheumatol. 2019 Aug;46(8):969-975. doi: 10.3899/jrheum.181070. Epub 2019 Feb 1.

39.

OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On.

Bruyn GA, Iagnocco A, Naredo E, Balint PV, Gutierrez M, Hammer HB, Collado P, Filippou G, Schmidt WA, Jousse-Joulin S, Mandl P, Conaghan P, Wakefield RJ, Keen HI, Terslev L, D'Agostino MA; OMERACT Ultrasound Working Group.

J Rheumatol. 2019 Feb 1. pii: jrheum.181095. doi: 10.3899/jrheum.181095. [Epub ahead of print]

PMID:
30709946
40.

Marked and rapid change of bone shape in acutely ACL injured knees - an exploratory analysis of the Kanon trial.

Bowes MA, Lohmander LS, Wolstenholme CBH, Vincent GR, Conaghan PG, Frobell RB.

Osteoarthritis Cartilage. 2019 Apr;27(4):638-645. doi: 10.1016/j.joca.2018.12.021. Epub 2019 Jan 14.

PMID:
30654120
41.

A Phase II Trial of Lutikizumab, an Anti-Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis.

Fleischmann RM, Bliddal H, Blanco FJ, Schnitzer TJ, Peterfy C, Chen S, Wang L, Feng S, Conaghan PG, Berenbaum F, Pelletier JP, Martel-Pelletier J, Vaeterlein O, Kaeley GS, Liu W, Kosloski MP, Levy G, Zhang L, Medema JK, Levesque MC.

Arthritis Rheumatol. 2019 Jul;71(7):1056-1069. doi: 10.1002/art.40840. Epub 2019 Jun 7.

PMID:
30653843
42.

Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.

Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS.

J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15.

PMID:
30647191
43.

The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis.

Smith TO, Hawker GA, Hunter DJ, March LM, Boers M, Shea BJ, Christensen R, Guillemin F, Terwee CB, Williamson PR, Dodd S, Roos EM, Loeser RF, Schnitzer TJ, Kloppenburg M, Neogi T, Ladel CH, Kalsi G, Kaiser U, Buttel TW, Ashford AE, Mobasheri A, Arden NK, Tennant A, Hochberg MC, de Wit M, Tugwell P, Conaghan PG.

J Rheumatol. 2019 Aug;46(8):981-989. doi: 10.3899/jrheum.181194. Epub 2019 Jan 15.

PMID:
30647185
44.

Report from the Hand Osteoarthritis Working Group at OMERACT 2018: Update on Core Instrument Set Development.

Wittoek R, Kroon FPB, Kundakci B, Abhishek A, Haugen IK, Berenbaum F, Conaghan PG, Ishimori ML, Smeets W, van der Heijde D, Kloppenburg M.

J Rheumatol. 2019 Sep;46(9):1183-1187. doi: 10.3899/jrheum.181003. Epub 2019 Jan 15.

PMID:
30647176
45.

The SPECTRA Collaboration OMERACT Working Group: Criterion Validity of Joint Space Outcomes with High Resolution Peripheral Quantitative Computed Tomography.

Manske SL, Brunet SC, Finzel S, Stok KS, Conaghan PG, Boyd SK, Barnabe C.

J Rheumatol. 2019 Jan 15. pii: jrheum.180870. doi: 10.3899/jrheum.180870. [Epub ahead of print]

PMID:
30647172
46.

Patient-reported outcome measures in osteoarthritis: a systematic search and review of their use and psychometric properties.

Lundgren-Nilsson Å, Dencker A, Palstam A, Person G, Horton MC, Escorpizo R, Küçükdeveci AA, Kutlay S, Elhan AH, Stucki G, Tennant A, Conaghan PG.

RMD Open. 2018 Dec 16;4(2):e000715. doi: 10.1136/rmdopen-2018-000715. eCollection 2018.

47.

Responsiveness of clinical and ultrasound outcome measures in musculoskeletal systemic lupus erythematosus.

Mahmoud K, Zayat AS, Yusof Y, Hensor E, Conaghan PG, Emery P, Vital EM.

Rheumatology (Oxford). 2019 Jan 3. doi: 10.1093/rheumatology/key422. [Epub ahead of print]

48.

Patients' preferences for osteoarthritis treatment: the value of stated-preference studies.

Hiligsmann M, Pinto D, Dennison E, Al-Daghri N, Beaudart C, Branco J, Bruyère O, Conaghan PG, Cooper C, Herrero-Beaumont G, Jiwa F, Lems W, Rizzoli R, Thomas T, Veronese N, Reginster JY.

Aging Clin Exp Res. 2019 Jan;31(1):1-3. doi: 10.1007/s40520-018-1098-3. Epub 2019 Jan 4. No abstract available.

49.

Longitudinal Reliability of the OMERACT Thumb Base Osteoarthritis Magnetic Resonance Imaging Scoring System (TOMS).

Kroon FPB, van Beest S, Gandjbakhch F, Peterfy CG, Chen S, Conaghan PG, Eshed I, Foltz V, Genant HK, Haugen IK, Medema JK, Østergaard M, Zhang L, Levesque MC, Kloppenburg M.

J Rheumatol. 2019 Sep;46(9):1228-1231. doi: 10.3899/jrheum.180949. Epub 2018 Dec 15.

PMID:
30554152
50.

Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities.

Baraliakos X, Conaghan PG, D'Agostino MA, Maksymowych W, Naredo E, Ostergaard M, Schett G, Emery P.

Eur J Rheumatol. 2019 Jan;6(1):38-47. doi: 10.5152/eurjrheum.2018.18121. Review.

Supplemental Content

Loading ...
Support Center